Sebia

Sebia

Sebia is a global leader in specialized in vitro diagnostics, providing instruments and reagents for screening and monitoring diseases in Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathies, Autoimmune and Infectious diseases, and other rare disorders. Its capillary electrophoresis portfolio is led by the CAPILLARYS 3 family—fully automated, multi-assay systems offering walkaway capability and high-throughput productivity. For autoimmune and infectious disease testing, Sebia provides ELISA and IFA solutions, including the fully automated Alegria 2* with Monotest Strip Technology and the dIFine P30 processor with dIFine automated microscope for digital IFA imaging and interpretation. Key assays include anti-MCV for Rheumatoid Arthritis and the Borrelia Modified Two-Tiered Testing (MTTT) algorithm.
*Not FDA Approved.

Contract Manufacturing, Data Analysis & Management/Middleware, Alcohol Testing, Anemia Testing, Animal Diagnostics, Autoimmune Disease Testing, Bacteriology, Bone Metabolism Testing, Cancer Testing, Coagulation/Hemostasis, Diabetes Testing, Electrophoresis, Enzyme Testing, Esoteric Testing, Genetic Screening, Genetic Testing, Glycolated Hemoglobin Testing, HbA1c Testing, Hematology, Hemoglobinopathy Testing, Infectious Disease Testing, Infectious Disease, Other, Laboratory Testing Services, Neonatal and Prenatal Testing, Protein Analysis, STD Testing, Thalassemia Testing, Toxicology, Viral Testing, Immunofluorescence, Capillary Electrophoresis, Chemiluminescence Systems, ELISA, Immunoassay Systems, Mass Spectrometry, Immunology, Virology, Microbiology, Serology, Biochemical Markers, Calibrators, Diabetes Markers, Enzymes, Immunoassay Diag/Reagents/Kits, Competency Assessment

No

Direct Sales